133 related articles for article (PubMed ID: 12012295)
1. Validity of prognostic models: when is a model clinically useful?
Vergouwe Y; Steyerberg EW; Eijkemans MJ; Habbema JD
Semin Urol Oncol; 2002 May; 20(2):96-107. PubMed ID: 12012295
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
[TBL] [Abstract][Full Text] [Related]
3. The clinical usefulness of prognostic prediction models in critical illness.
Baker T; Gerdin M
Eur J Intern Med; 2017 Nov; 45():37-40. PubMed ID: 28935477
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with carcinomas of the testicle, prostate, and bladder.
Stewart DJ
Trans Assoc Life Insur Med Dir Am; 1987; 70():87-113. PubMed ID: 3037755
[No Abstract] [Full Text] [Related]
6. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
7. Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics.
Hukkelhoven CW; Steyerberg EW; Habbema JD; Farace E; Marmarou A; Murray GD; Marshall LF; Maas AI
J Neurotrauma; 2005 Oct; 22(10):1025-39. PubMed ID: 16238481
[TBL] [Abstract][Full Text] [Related]
8. Assessing the discriminative ability of risk models for more than two outcome categories.
Van Calster B; Vergouwe Y; Looman CW; Van Belle V; Timmerman D; Steyerberg EW
Eur J Epidemiol; 2012 Oct; 27(10):761-70. PubMed ID: 23054032
[TBL] [Abstract][Full Text] [Related]
9. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.
Harrell FE; Lee KL; Mark DB
Stat Med; 1996 Feb; 15(4):361-87. PubMed ID: 8668867
[TBL] [Abstract][Full Text] [Related]
10. Quantifying prognosis with risk predictions.
Pace NL; Eberhart LH; Kranke PR
Eur J Anaesthesiol; 2012 Jan; 29(1):7-16. PubMed ID: 22089517
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia.
Afriansyah A; Hamid ARA; Mochtar CA; Umbas R
Int J Urol; 2019 Jan; 26(1):83-89. PubMed ID: 30269369
[TBL] [Abstract][Full Text] [Related]
13. Modeling Clinical Outcomes in Prostate Cancer: Application and Validation of the Discrete Event Simulation Approach.
Pan F; Reifsnider O; Zheng Y; Proskorovsky I; Li T; He J; Sorensen SV
Value Health; 2018 Apr; 21(4):416-422. PubMed ID: 29680098
[TBL] [Abstract][Full Text] [Related]
14. Sequential testing approach as an efficient and easier alternative for the validation of new predictive technologies in the clinic.
Beam CA; Gao W; Macias V; Liang W; Kajdacsy Balla A
J Clin Oncol; 2009 Mar; 27(7):1087-90. PubMed ID: 19139434
[TBL] [Abstract][Full Text] [Related]
15. A discussion of calibration techniques for evaluating binary and categorical predictive models.
Fenlon C; O'Grady L; Doherty ML; Dunnion J
Prev Vet Med; 2018 Jan; 149():107-114. PubMed ID: 29290291
[TBL] [Abstract][Full Text] [Related]
16. Introduction of a novel measure of premature mortality caused by chronic conditions: real-world examples from prostate and testis cancers in Canada, 1980-2015.
Pham TM; Shack L; Cheung WY
Ann Epidemiol; 2019 Sep; 37():81-83. PubMed ID: 31427150
[No Abstract] [Full Text] [Related]
17. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
[TBL] [Abstract][Full Text] [Related]
18. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
Steyerberg EW; Gerl A; Fossá SD; Sleijfer DT; de Wit R; Kirkels WJ; Schmeller N; Clemm C; Habbema JD; Keizer HJ
J Clin Oncol; 1998 Jan; 16(1):269-74. PubMed ID: 9440752
[TBL] [Abstract][Full Text] [Related]
19. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.
Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L
Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
